The Howard County Board of Education is suing Eli Lilly and Co., Novo Nordisk, CVS, United Health group and several other ...

The addition of anagliptin to insulin and metformin therapy may improve glycemic control in patients with type 2 diabetes while maintaining an acceptable safety profile.

IcoSema, a combination therapy of basal insulin icodec and semaglutide, achieves a noninferior reduction in A1c levels compared with basal-bolus therapy in adults with T2D.

The craziest way science has found to help reverse insulin resistance is drinking lemon juice. Scientific research is now ...

Children with diabetes who inhaled their mealtime doses of insulin did just as well as those who injected insulin under the ...

Scientists have identified a simple blood test that measures insulin resistance which may also help doctors determine which ...

The diabetes conference featured a debate about over-the-counter glucose monitors and updates on upcoming devices, including ...

A study finds that inhaled insulin is as effective as traditional injections for children with type 1 diabetes during ...

Pregnant women with type 1 diabetes who used hybrid closed-loop insulin delivery with Control-IQ technology spent more time ...

CHICAGO -- A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the ...

CHICAGO -- An investigational allogeneic stem cell-derived islet-cell therapy helped almost all patients with type 1 diabetes ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.